AlloStar
AI-physics hybrid platform for allosteric drug discovery
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
AlloStar is Nutshell Therapeutics' proprietary AI-physics hybrid drug discovery platform used to design allosteric modulators for targets that are difficult to address with conventional approaches. Public company materials describe applications across allosteric inhibitors, activators, PPI modulators, and related modalities in oncology and other disease areas.
- Website
- allonutshell.cn/index.html
- Added via
- web
- Ownership
- unclaimed
Where to go
Product details
- Product kind
- Other